An evolutionary explanation for antibiotics’ association with increased colon cancer risk
Author(s) -
Konstantinos Voskarides
Publication year - 2022
Publication title -
evolution medicine and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 22
ISSN - 2050-6201
DOI - 10.1093/emph/eoac018
Subject(s) - antibiotics , colorectal cancer , dna mismatch repair , selection (genetic algorithm) , biology , cancer , gut flora , antibiotic resistance , mutagenesis , bioinformatics , mutation , genetics , immunology , gene , artificial intelligence , computer science
More than 10 studies have confirmed the association of antibiotic overuse with colorectal cancer. The exact cause is unknown, but most authors hypothesize that disturbance of colon microbiota is the main culprit. In this commentary an evolutionary explanation is proposed. It is well known that antibiotics can induce antibiotic resistance in bacteria through selection of mutators—DNA mismatch repair deficient (dMMR) strains. Mutators have an increased survival potential due to their high mutagenesis rate. Antibiotics can also cause stress in human cells. Selection of dMMR colon cells may be advantageous under this stress, mimicking selection of bacterial mutators. Concomitantly, MMR deficiency is a common cause of cancer, this may explain the increased cancer risk after multiple cycles of oral antibiotics. This proposed rationale is described in detail, along with supporting evidence from the peer-reviewed literature and suggestions for testing hypothesis validity. Treatment schemes could be re-evaluated, considering toxicity and somatic selection mechanisms. LAY SUMMARY The association of antibiotics with colon cancer is well established but of unknown cause. Under an evolutionary framework, antibiotics may select for stress resistant cancerous cells that lack mechanisms for DNA mismatch repair (MMR). This mimics the selection of antibiotic resistant “mutators”- MMR deficient micro-organisms- highly adaptive due to their increased mutagenesis rate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom